Your browser doesn't support javascript.
loading
Efficacy and safety of lixisenatide in elderly (≥65 years old) and very elderly (≥75 years old) patients with type 2 diabetes: an analysis from the GetGoal phase III programme.
Raccah, Denis; Miossec, Patrick; Esposito, Virginie; Niemoeller, Elisabeth; Cho, Meehyung; Gerich, John.
Affiliation
  • Raccah D; Department of Diabetology, University Hospital Sainte Marguerite, Marseille, France.
Diabetes Metab Res Rev ; 31(2): 204-11, 2015 Feb.
Article in En | MEDLINE | ID: mdl-25115916
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Aging / Receptors, Glucagon / Diabetes Mellitus, Type 2 / Hyperglycemia / Hypoglycemic Agents Type of study: Clinical_trials / Systematic_reviews Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Metab Res Rev Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2015 Document type: Article Affiliation country: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Aging / Receptors, Glucagon / Diabetes Mellitus, Type 2 / Hyperglycemia / Hypoglycemic Agents Type of study: Clinical_trials / Systematic_reviews Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Metab Res Rev Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2015 Document type: Article Affiliation country: France